GLP-1 receptor agonist use during hospitalisation: Better glycaemic control compared to premixed insulin.

MLA

Jervis, Morgan, et al. “GLP-1 Receptor Agonist Use during Hospitalisation: Better Glycaemic Control Compared to Premixed Insulin.” Diabetes/Metabolism Research and Reviews, vol. 38, no. 8, Nov. 2022, p. e3574. EBSCOhost, https://doi.org/10.1002/dmrr.3574.

APA

Jervis, M., Mitchell, A. P., Islam, N., Mustafa, O. G., Kelly, P. A., & Whyte, M. B. (2022). GLP-1 receptor agonist use during hospitalisation: Better glycaemic control compared to premixed insulin. Diabetes/Metabolism Research and Reviews, 38(8), e3574. https://doi.org/10.1002/dmrr.3574

Chicago

Jervis, Morgan, Antonine Pineau Mitchell, Nafseen Islam, Omar G Mustafa, Philip A Kelly, and Martin B Whyte. 2022. “GLP-1 Receptor Agonist Use during Hospitalisation: Better Glycaemic Control Compared to Premixed Insulin.” Diabetes/Metabolism Research and Reviews 38 (8): e3574. doi:10.1002/dmrr.3574.